Cancer
Conditions
Keywords
Cancer
Brief summary
The MGH Cancer Center's patient navigation (PN) program, utilizes specially trained community-based personnel to improve cancer care in underserved communities by increasing cancer screening and removing barriers to timely care. This program incorporate rigorous evaluation to demonstrate the impact of innovation in healthcare delivery.
Detailed description
This program allow cancer patients from MGH Community Health Centers (CHC) and surrounding communities who experience barriers to accessing care, including poverty, and limited English proficiency, and provide them navigation to receive timely, guideline-concordant treatment at MGH Cancer Center. By offering these vulnerable individuals a patient-centered approach to treatment, The investigators aim to promote patient engagement and increase access throughout the continuum of cancer care.
Interventions
PN program improve access, timeliness and adherence with cancer treatment
OTHERUsual Care
the standard of care provided by the institution
Sponsors
Massachusetts General Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult patients (age 18 and older) * Newly diagnosed with cancer referred from Massachusetts General Hospital (MGH) community health centers in * Revere * Chelsea * Charlestown * surrounding communities referred to receive cancer treatment at the MGH Cancer Center
Exclusion criteria
-Patients that primary care providers exclude
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adherence With Cancer Treatment | 2 years | Adherence with cancer treatment will be measured as no-show rate to scheduled oncology appointments. |
| The Time From Cancer Diagnosis To First Oncology Appointment | 2 Years | Length of time in days from cancer diagnosis to first completed oncology appointment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Overall Survival | 2 years | Overall survival rate of the study population. |
| Proportion Of Patients Enrolled In Clinical Trials | 2 years | Proportion of participants in the study that enroll on a clinical trial. |
| Overall Missed Health Care Visits | 2 years | Number of scheduled health care visits missed by enrolled patients. |
| Unplanned Hospitalizations/Readmissions | 2 years | Number of unplanned hospitalizations and/or readmissions by enrolled patients. |
| Emergency Department Visits | 2 years | Number of emergency department visits by enrolled patients. |
| Patient Satisfaction With Patient Navigation Program (PNP) | 2 years | Patient satisfaction with patient navigation program (PNP) to be measured via the validated Patient Satisfaction with Navigation - 1 (PSN-1). |
| Patient Engagement In Care | 2 years | Patient engagement in care will be measured using the validated Perceived Efficacy in Patient-Physician Interactions (PEPPI) metric. |
| Patient's Financial Burden | 2 years | Patient financial burden will be measured using the validated Comprehensive Score for Financial Toxicity (COST) instrument. |
| Patient Satisfaction with Cancer Care | 2 years | Patient satisfaction with cancer care to be measured using the validated Cancer-Related Care Survey. |
| Inpatient Hospitalization Length Of Stay. | 2 years | Number of days enrolled patients spent as a hospitalized inpatient. |
| Health Related Quality Of Life | 2 years | Health related quality of life measured via the validated Functional Assessment of Cancer Therapy - General (FACT-G). |
Countries
United States
Contacts
Primary ContactEmma Whited
Outcome results
None listed